Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04642352 · ClinicalTrials.gov registry record
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
A clinical trial of Cough, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04642352 is a study of Cough that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 218-participant average among 12 other Cough trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04642352, a study of Cough, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate if office-based injection of a local anesthetic/steroid combination at the area of one superior laryngeal nerve can decrease cough frequency and alleviate symptoms of chronic cough in patients with neurogenic cough.
Conditions Studied
Interventions
- DRUG superior laryngeal nerve block
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04642352
The ClinicalTrials.gov registry entry for NCT04642352 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 12 other Cough trials with a reported enrollment target (77% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cough appearing as the primary indexed condition, and to 1 intervention - of which superior laryngeal nerve block is the first listed.
NCT04642352 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04642352 about?
NCT04642352 is a clinical study titled "Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough". The purpose of this study is to evaluate if office-based injection of a local anesthetic/steroid combination at the area of one superior laryngeal nerve can decrease cough frequency and alleviate symptoms of chronic cough in patients with neurogenic cough.
What is the current status of trial NCT04642352?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-01-03. Estimated completion is 2026-10.
What conditions does trial NCT04642352 study?
This clinical trial studies the following conditions: Cough.
What interventions are being tested in trial NCT04642352?
The interventions under investigation include: superior laryngeal nerve block (DRUG).
Who is sponsoring clinical trial NCT04642352?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04642352 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cough
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
RECRUITING · Phase 3
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
-
Stimulation of the Larynx to Treat Unexplained Chronic Cough
RECRUITING · NA
-
Work of Breathing Assessment in Triage Scale
ACTIVE NOT RECRUITING
-
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
ACTIVE NOT RECRUITING · Phase 3
-
Stimulation With Wire Leads to Restore Cough
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.